Showing 11,101 - 11,120 results of 44,402 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((teer decrease) OR (mean decrease)) ))', query time: 1.19s Refine Results
  1. 11101

    Dog-bone specimens before tensile testing. by Shaheer Ahmed Khan (17797647)

    Published 2025
    “…The tensile strength of ABS polymer decreases as the traverse speed increases from 10 mm/min to 50 mm/min at both rotational speeds of 800 and 1200 rpm. …”
  2. 11102

    Experimental run of FSW on CNC milling machine. by Shaheer Ahmed Khan (17797647)

    Published 2025
    “…The tensile strength of ABS polymer decreases as the traverse speed increases from 10 mm/min to 50 mm/min at both rotational speeds of 800 and 1200 rpm. …”
  3. 11103

    Proliferative marker PCNA expression in the squamous epithelium in 3D OTC-ALI in response to conditioned media from untreated, pH4.5 and pH4.5 bile salt treated HEMFs conditioned m... by Liping Hu (172765)

    Published 2020
    “…Quantification of PCNA per DAPI+ cells demonstrates a decrease in PCNA expression in epithelial cells established with conditioned media from pH 4.5 and pH 4.5 bile salt treated HEMFs vs untreated HEMFs. …”
  4. 11104

    DataSheet_1_Disruptive effects of plasticizers bisphenol A, F, and S on steroidogenesis of adrenocortical cells.docx by Benedikt Pötzl (18854980)

    Published 2024
    “…For BPF, levels of 17-hydroxyprogesterone were significantly increased by 25µM (FC 2.57±0.49, p≤0.001) and 50µM (FC 2.65±0.61, p≤0.0001). BPS treatment led to a dose-dependent decrease of 11-deoxycorticosterone at >1µM (e.g. …”
  5. 11105
  6. 11106
  7. 11107
  8. 11108
  9. 11109
  10. 11110
  11. 11111
  12. 11112
  13. 11113
  14. 11114
  15. 11115
  16. 11116
  17. 11117
  18. 11118
  19. 11119

    Image_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
  20. 11120

    Image_2_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”